Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OVID | AZN | AMGN | GILD | VRTX |
| Company | Ovid Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.3470 | 70.25 | 280.63 | 103.86 | 495.40 |
| High | 0.3640 | 70.81 | 284.10 | 106.11 | 498.65 |
| Low | 0.3425 | 69.53 | 280.00 | 103.14 | 490.37 |
| Last | 0.3461 | 69.66 | 281.97 | 106.27 | 494.69 |
| Change | -0.0008 | +0.09 | +1.13 | +3.10 | +0.85 |
| % Change | -0.23% | +0.13% | +0.40% | +3.00% | +0.17% |
| Volume | 660,875 | 5,586,193 | 908,912 | 4,540,366 | 614,490 |
| 20-Day Average Volume | 488,847 | 6,839,181 | 3,191,979 | 9,666,418 | 1,678,696 |
| Previous Close | 0.3469 | 69.57 | 280.84 | 103.17 | 493.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2983 | 68.59 | 288.88 | 106.34 | 485.56 |
| 20-Day Raw Stochastic | 86.09% | 58.02% | 28.42% | 58.42% | 82.14% |
| 20-Day Relative Strength | 44.25% | 47.74% | 42.36% | 48.93% | 52.80% |
| Weighted Alpha | -73.61 | -9.77 | -11.43 | +58.29 | +19.36 |
| Today's Opinion | 88% Sell | 56% Sell | 56% Sell | 40% Buy | 56% Buy |
| Previous Opinion | 88% Sell | 56% Sell | 56% Sell | 40% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 8% Sell | 16% Buy | 80% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +21.62% since 04/21/25 | +4.08% since 04/21/25 | +2.65% since 04/21/25 | +1.47% since 04/21/25 | +3.15% since 04/21/25 |
| Low | 0.2807 on 04/22/25 | 66.87 on 04/22/25 | 274.42 on 04/24/25 | 93.37 on 04/25/25 | 480.56 on 04/22/25 |
| High | 0.3640 on 04/28/25 | 70.81 on 04/28/25 | 284.10 on 04/28/25 | 107.56 on 04/24/25 | 498.65 on 04/28/25 |
| 1-Month | |||||
| %Chg | -0.83% since 03/28/25 | -5.64% since 03/28/25 | -8.48% since 03/28/25 | -5.30% since 03/28/25 | -0.03% since 03/28/25 |
| Low | 0.2425 on 04/09/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 448.14 on 04/07/25 |
| High | 0.3640 on 04/28/25 | 75.70 on 04/03/25 | 315.00 on 03/31/25 | 114.75 on 04/03/25 | 502.22 on 04/16/25 |
| 3-Month | |||||
| %Chg | -52.31% since 01/28/25 | +0.06% since 01/28/25 | +0.22% since 01/28/25 | +12.80% since 01/28/25 | +11.77% since 01/28/25 |
| Low | 0.2425 on 04/09/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 430.81 on 01/29/25 |
| High | 0.8079 on 01/29/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -70.33% since 10/28/24 | -8.39% since 10/28/24 | -11.43% since 10/28/24 | +19.27% since 10/28/24 | +3.40% since 10/28/24 |
| Low | 0.2425 on 04/09/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 86.08 on 11/19/24 | 377.85 on 12/19/24 |
| High | 1.4700 on 11/11/24 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,015 | 212,311,376 | 158,279,088 | 133,543,728 | 121,877,672 |
| Shares Outstanding, K | 71,075 | 3,101,247 | 537,651 | 1,245,163 | 256,790 |
| Annual Sales | 570,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -26,430,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 80,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -9,250,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 0.44 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 03/11/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.81 on 04/24/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 05/13/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.93 | 14.17 | 13.33 | 0.00 |